| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.2870 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.3660 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.4126 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.4479 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.4987 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.5373 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.5384 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.5444 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.5578 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.5872 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.6098 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.6114 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.6252 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.6461 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.6553 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.6565 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.6571 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.6625 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.7171 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.7451 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.7593 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.7644 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.7754 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.7759 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.7807 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.7926 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8053 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8134 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8157 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8175 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8273 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8353 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8360 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8362 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8400 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8433 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8556 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8689 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8704 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8748 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8829 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8890 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8927 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8942 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.8974 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9029 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9057 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9176 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9198 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9198 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9247 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9325 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9459 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9536 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9597 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9653 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9683 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9697 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9700 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9705 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9827 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9901 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9912 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9940 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 0.9956 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0000 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0043 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0053 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0104 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0123 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0244 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0307 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0357 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0416 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0435 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0446 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0455 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0472 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0568 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0614 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0650 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0652 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0681 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0853 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0895 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.0910 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1079 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1132 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1196 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1275 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1298 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1360 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1416 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1419 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1423 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1591 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1647 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1690 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1790 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1835 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1884 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.1996 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.2223 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.2228 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.2405 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.2417 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.2505 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.2646 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.2653 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.2773 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.2843 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.2959 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.3134 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.3226 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.3678 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.3779 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.3812 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.4197 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.4198 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.4357 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.4358 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.4388 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.4690 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.4744 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.4909 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.4924 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.5390 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.6444 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.6693 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.6730 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | palmitate (16:0) | 1.7076 | Peak area | Obese non neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|